TRT interruption reduced TT to hypogonadal levels in Group A and resulted in worsening of obesity parameters, AMS, IPSS, residual voiding volume and bladder wall thickness, IIEF-EF, and PSA, while CRP and prostate volume were unchanged until treatment resumed whereby these effects were reversed. The gene discussed is CRP; the disease is Obesity.